Generic Drugs Market Research
Discover insightful information you need to be fully informed on the Generic Drugs Market. Reports include data on the Threats and Opportunities of Generic Drugs in today’s market place.
first
previous
Title  | Date  | Price |
|---|---|---|
| Salmeterol Pipeline Developer | Mar 2009 | £2,995 |
| Roxithromycin Pipeline Developer | Mar 2009 | £2,995 |
| Tiotropium Bromide Pipeline Developer | Mar 2009 | £3,440 |
| Topiramate Pipeline Developer | Mar 2009 | £2,995 |
| Zolmitriptan Pipeline Developer | Mar 2009 | £2,995 |
| Rosuvastatin Pipeline Developer | Mar 2009 | £3,440 |
| Rosiglitazone Pipeline Developer | Mar 2009 | £3,885 |
| Rivastigmine Pipeline Developer | Mar 2009 | £2,995 |
| Rizatriptan Pipeline Developer | Mar 2009 | £3,440 |
| Ropinirole Pipeline Developer | Mar 2009 | £2,995 |
| Ropivacaine Pipeline Developer | Mar 2009 | £2,545 |
| Tacrolimus Pipeline Developer | Mar 2009 | £3,440 |
| Tadalafil Pipeline Developer | Mar 2009 | £3,440 |
| Generic Benchmarking: Brand Erosion at Patent Expiry Healthcare | Mar 2009 | £4,635 |
| Research Report on China's Biopharmaceutical Industry, 2009 | Mar 2009 | £1,175 |
| U.S. Market for Anti-Adhesion Products 2009 | Mar 2009 | £4,505 |
| Sunitinib Pipeline Developer | Mar 2009 | £3,440 |
| Zolazepam (Vet) Pipeline Developer | Mar 2009 | £2,100 |
| Zoledronic Acid Pipeline Developer | Mar 2009 | £3,440 |
| Temozolomide Pipeline Developer | Mar 2009 | £2,995 |
| Tamsulosin Pipeline Developer | Mar 2009 | £2,995 |
| Tazobactam Pipeline Developer | Mar 2009 | £2,545 |
| Tolterodine Pipeline Developer | Mar 2009 | £2,995 |
| Temsirolimus Pipeline Developer | Mar 2009 | £3,885 |
| Ritonavir Pipeline Developer | Mar 2009 | £3,885 |
| Risperidone Pipeline Developer | Mar 2009 | £2,545 |
| Sildenafil Pipeline Developer | Mar 2009 | £3,440 |
| Riluzole Pipeline Developer | Mar 2009 | £2,545 |
| Simvastatin Pipeline Developer | Mar 2009 | £2,545 |
| Sirolimus Pipeline Developer | Mar 2009 | £4,425 |
| Sitagliptin Pipeline Developer | Mar 2009 | £3,885 |
| Imatinib Pipeline Developer | Mar 2009 | £3,885 |
| Dasatinib Pipeline Developer | Mar 2009 | £2,995 |
| Candesartan Pipeline Developer | Mar 2009 | £3,885 |
| Capecitabine Pipeline Developer | Mar 2009 | £2,995 |
| Carprofen (Vet) Pipeline Developer | Mar 2009 | £2,545 |
| Carvedilol Pipeline Developer | Mar 2009 | £2,545 |
| Solifenacin Pipeline Developer | Mar 2009 | £2,995 |
| Sorafenib Pipeline Developer | Mar 2009 | £3,885 |
| Sevelamer Pipeline Developer | Mar 2009 | £2,995 |
| Sertraline Pipeline Developer | Mar 2009 | £2,995 |
| Rimonabant Pipeline Developer | Mar 2009 | £3,440 |
| Risedronic Acid Pipeline Developer | Mar 2009 | £2,995 |
| Tigecycline Pipeline Developer | Mar 2009 | £3,440 |
| Tibolone Pipeline Developer | Mar 2009 | £2,100 |
| Tenofovir Pipeline Developer | Mar 2009 | £3,885 |
| Terbinafine Pipeline Developer | Mar 2009 | £2,545 |
| Teriparatide Pipeline Developer | Mar 2009 | £3,885 |
| Thalidomide Pipeline Developer | Mar 2009 | £3,440 |
| Trandolapril Pipeline Developer | Mar 2009 | £2,545 |
| Trastuzumab Pipeline Developer | Mar 2009 | £4,425 |
| Galantamine Pipeline Developer | Mar 2009 | £3,440 |
| Gefitinib Pipeline Developer | Mar 2009 | £3,440 |
| Gadopentetic acid Pipeline Developer | Mar 2009 | £3,440 |
| Gabapentin Pipeline Developer | Mar 2009 | £2,545 |
| Frovatriptan Pipeline Developer | Mar 2009 | £3,440 |
| Gemcitabine Pipeline Developer | Mar 2009 | £2,995 |
| Imidacloprid (Vet) Pipeline Developer | Mar 2009 | £2,995 |
| Fluvastatin Pipeline Developer | Mar 2009 | £3,440 |
| Hepatitis B Vaccine Pipeline Developer | Mar 2009 | £4,425 |
| Ibandronic Acid Pipeline Developer | Mar 2009 | £2,995 |
| Glatiramer acetate Pipeline Developer | Mar 2009 | £3,440 |
| Fosinopril Pipeline Developer | Mar 2009 | £2,545 |
| Erlotinib Pipeline Developer | Mar 2009 | £3,440 |
| Quinapril Pipeline Developer | Mar 2009 | £2,545 |
| Rabeprazole Pipeline Developer | Mar 2009 | £3,885 |
| Ractopamine (Vet) Pipeline Developer | Mar 2009 | £2,100 |
| Raloxifene Pipeline Developer | Mar 2009 | £3,885 |
| Quetiapine Pipeline Developer | Mar 2009 | £2,995 |
| Pregabalin Pipeline Developer | Mar 2009 | £2,995 |
| Eptifibatide Pipeline Developer | Mar 2009 | £3,440 |
| Pyriproxyfen (Vet) Pipeline Developer | Mar 2009 | £2,545 |
| Reboxetine Pipeline Developer | Mar 2009 | £3,440 |
| Pravastatin Pipeline Developer | Mar 2009 | £2,995 |
| Fluticasone Pipeline Developer | Mar 2009 | £3,440 |
| Fludarabine Pipeline Developer | Mar 2009 | £4,735 |
| Voriconazole Pipeline Developer | Mar 2009 | £3,885 |
| Venlafaxine Pipeline Developer | Mar 2009 | £2,545 |
| Zidovudine Pipeline Developer | Mar 2009 | £3,440 |
| Ziprasidone Pipeline Developer | Mar 2009 | £3,885 |
| Research Report on Chinese Anti-Tumor Drug Market, 2009 | Mar 2009 | £865 |
| Varenicline Pipeline Developer | Mar 2009 | £2,995 |
| Vardenafil Pipeline Developer | Mar 2009 | £3,440 |
| Travoprost Pipeline Developer | Mar 2009 | £2,995 |
| Valaciclovir Pipeline Developer | Mar 2009 | £3,440 |
| Valganciclovir Pipeline Developer | Mar 2009 | £3,440 |
| Valsartan Pipeline Developer | Mar 2009 | £3,885 |
| Glimepiride Pipeline Developer | Mar 2009 | £2,545 |
| Fluconazole Pipeline Developer | Mar 2009 | £2,100 |
| Ezetimibe Pipeline Developer | Mar 2009 | £3,885 |
| Exemestane Pipeline Developer | Mar 2009 | £2,995 |
| Everolimus Pipeline Developer | Mar 2009 | £3,885 |
| Ertapenem Pipeline Developer | Mar 2009 | £3,885 |
| Famciclovir Pipeline Developer | Mar 2009 | £2,995 |
| Fesoterodine Pipeline Developer | Mar 2009 | £3,440 |
| Florfenicol (Vet) Pipeline Developer | Mar 2009 | £2,545 |
| Fipronil (Vet) Pipeline Developer | Mar 2009 | £2,995 |
| Finasteride Pipeline Developer | Mar 2009 | £2,545 |
| Fexofenadine Pipeline Developer | Mar 2009 | £2,545 |
| Repaglinide Pipeline Developer | Mar 2009 | £2,995 |
Filter Results by
Industry Events
Innovations in Oncology Drug Discovery, Development & Delivery
01 Dec 09 to 01 Dec 09
N/A, UK
view summary >>
2nd International Conference on Drug Discovery and Therapy
01 Feb 10 to 04 Feb 10
Dubai, United Arab Emirates
view summary >>
Pharma & Healthcare
- Animal / Veterinary
- Biotechnology
- Cardiovascular
- Company Financials
- Company Reports (Pharmaceutical)
- Country Reports (Pharmaceutical)
- Deals & Alliances
- Dental
- Diagnostics
- Dietary
- Diseases
- Drug Delivery
- Drug Discovery
- Finance / Investment
- General Industry
- Generic Drugs
- Healthcare
- IT & eHealth
- Management / Strategy
- Medical Devices
- Medical Supplies
- OTC drugs
- Pharma Chemicals
- Pharmacy
- Prescription Drugs
- Production / Manufacturing
- Regulation & Policy
- Research (R&D)
- Sales & Marketing
- Technology
- Therapeutic
- Treatments
call +44 (0) 20 7060 7474
or email us
